BioSpace News Archive

The patent now granted by the Japan Patent Office is valid until 2035. Diamyd Medical recently announced the grant of the corresponding patent in Europe . The patents primarily protect the administration method of Diamyd ® that is now being evaluated in the Phase IIb trial DIAGNODE-2 and which previously showed positive results in t

As VisiQuate Inc. continues to grow and expand into new areas of healthcare, the company today announced that Jim Lacy and Karl Robb, both of whom are widely known and highly respected figures in their industries, have joined its Board of Directors.

Quanterix Corporation (NASDAQ: QTRX), a company digitizing analysis to advance the science of precision health, today announced a call for proposals for the Simoa® Success Grant Program.

Marrone Bio Innovations, Inc. (Nasdaq: MBII) (the “Company”) today announced that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) as a result of the company’s closing bid price being below $1.00 per share for 30 consecutive days.

Hebron Technology Co., Ltd. (“Hebron” or the “Company”) (Nasdaq: HEBT), a technology oriented enterprise group conducting business in the pharmaceutical equipment and engineering industry segment and financial service industry segment, today announced its financial results for the fiscal year ended December 31, 2019.

Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2020 after market close on Thursday, May 14, 2020.

The National Institutes of Health (NIH) released a statement this week warning against the use of hydroxychloroquine (HCQ) in combination with azithromycin.

BioChek, the specialist company to offer innovative and user-friendly veterinary diagnostic tools, today announced the successful acquisition of BIOTECON, specialised in development and manufacturing of PCR based solutions for food safety diagnostics. The merger creates a new, leading global player in Veterinary and Food

Rates Higher in New York City Metro Area Findings Mirror Studies Showing Prevalence Likely Far Higher than Official Reports

Company’s subsidiary ViralClear recently submitted an Investigational New Drug application to the FDA for its Phase II clinical trial with Merimepodib as a treatment for COVID-19